HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wei-Ming Li Selected Research

Acute Myelomonocytic Leukemia

10/2006[Depressing the immune escape of acute myelomonocytic leukemia via an anti-Fas ribozyme].
6/2006[Expression of immune response molecules and function of fas ligand on surface of AML WEHI-3 cells].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wei-Ming Li Research Topics

Disease

48Neoplasms (Cancer)
02/2022 - 08/2009
46Carcinoma (Carcinomatosis)
05/2022 - 02/2007
14Neoplasm Metastasis (Metastasis)
03/2020 - 02/2007
9Carcinogenesis
01/2022 - 12/2012
6Inflammation (Inflammations)
10/2022 - 01/2012
5Urinary Bladder Neoplasms (Bladder Cancer)
11/2021 - 02/2007
3Cardiovascular Diseases (Cardiovascular Disease)
12/2022 - 06/2007
3ST Elevation Myocardial Infarction
01/2021 - 10/2011
3Hypoxia (Hypoxemia)
07/2018 - 09/2017
3Breast Neoplasms (Breast Cancer)
05/2018 - 12/2015
3Ischemia
03/2017 - 07/2008
3Urolithiasis
05/2012 - 06/2007
3Myocardial Infarction
02/2010 - 04/2007
2Chronic Renal Insufficiency
11/2021 - 08/2009
2Transitional Cell Carcinoma
12/2019 - 08/2009
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2018 - 12/2007
2Cardiomegaly (Heart Hypertrophy)
01/2017 - 01/2016
2Atherosclerosis
01/2016 - 12/2012
2Lymphatic Metastasis
07/2015 - 12/2012
2Type 2 Diabetes Mellitus (MODY)
01/2013 - 12/2012
2Coronary Artery Disease (Coronary Atherosclerosis)
03/2012 - 06/2007
2Erectile Dysfunction
03/2012 - 11/2009
2Infarction (Infarctions)
02/2010 - 10/2007
2Hyperplasia
11/2009 - 01/2009
2Diabetes Mellitus
04/2009 - 01/2009
2Shock
10/2008 - 01/2007
2Acute Myelomonocytic Leukemia
10/2006 - 06/2006
1Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
12/2022
1Heart Failure
12/2022
1Death (Near-Death Experience)
12/2022
1Infections
10/2022
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
12/2021
1Disease Progression
06/2021
1Acute Promyelocytic Leukemia
01/2021
1Liver Cirrhosis (Hepatic Cirrhosis)
09/2020
1Heart Injuries
09/2020
1Porcine Reproductive and Respiratory Syndrome (PRRS)
07/2020
1Disease Resistance
07/2020

Drug/Important Bio-Agent (IBA)

13Proteins (Proteins, Gene)FDA Link
01/2020 - 03/2013
9Biomarkers (Surrogate Marker)IBA
01/2021 - 09/2012
5MicroRNAs (MicroRNA)IBA
02/2022 - 01/2019
5Biological ProductsIBA
12/2021 - 08/2007
3Hemoglobins (Hemoglobin)IBA
11/2021 - 01/2016
3Messenger RNA (mRNA)IBA
01/2020 - 07/2014
3Indicators and Reagents (Reagents)IBA
01/2016 - 01/2013
3Uric Acid (Urate)IBA
05/2012 - 06/2007
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
12/2022 - 01/2017
2Glucose (Dextrose)FDA LinkGeneric
12/2021 - 12/2012
2CreatinineIBA
04/2019 - 01/2009
2Tyrosine Kinase InhibitorsIBA
12/2018 - 12/2007
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
05/2018 - 01/2013
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2018 - 08/2007
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2017 - 03/2015
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
11/2015 - 07/2015
2Membrane Proteins (Integral Membrane Proteins)IBA
04/2015 - 09/2013
2Cyclin AIBA
10/2013 - 12/2012
2RNA-Binding Proteins (RNA-Binding Protein)IBA
10/2013 - 12/2012
2LDL Receptors (LDL Receptor)IBA
12/2012 - 01/2012
2LipidsIBA
12/2012 - 01/2012
2Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2012 - 11/2009
2Tirofiban (Aggrastat)FDA Link
10/2011 - 02/2010
2omega-Chloroacetophenone (Mace)IBA
10/2011 - 06/2007
2Testosterone (Sustanon)FDA Link
04/2009 - 10/2007
2Fas Ligand Protein (Fas Ligand)IBA
10/2006 - 06/2006
1Phosphoprotein Phosphatases (Phosphatases, Protein)IBA
12/2022
1Dual-Specificity PhosphatasesIBA
12/2022
1fucoidanIBA
10/2022
1Oncogene Proteins (Oncogene Protein)IBA
01/2022
1UbiquitinIBA
01/2022
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2022
1Ubiquitin-Specific ProteasesIBA
01/2022
1Deubiquitinating EnzymesIBA
01/2022
1MetalsIBA
01/2022
1MetallothioneinIBA
01/2022
1Complement System Proteins (Complement)IBA
12/2021
1CCAAT-Enhancer-Binding Protein-deltaIBA
12/2021
1Receptor Tyrosine Kinase-like Orphan ReceptorsIBA
08/2021
1ParaffinIBA
07/2021
1TransaldolaseIBA
07/2021
1Arsenic Trioxide (Trisenox)FDA Link
01/2021
1Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2021
1CytokinesIBA
12/2020
1Malondialdehyde (Propanedial)IBA
12/2020
1Glutathione PeroxidaseIBA
12/2020
1monotropeinIBA
12/2020
1Superoxide DismutaseIBA
12/2020
1Pattern Recognition ReceptorsIBA
07/2020
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
03/2020
1microtubule-associated protein 1B (MAP5)IBA
03/2020
1Anticarcinogenic AgentsIBA
01/2020

Therapy/Procedure

15Nephroureterectomy
05/2022 - 08/2009
7Therapeutics
01/2021 - 10/2007
5Adjuvant Chemotherapy
02/2022 - 12/2012
4Percutaneous Coronary Intervention
01/2021 - 10/2007
4Stents
02/2010 - 04/2007
3Cystectomy
01/2022 - 02/2007
3Precision Medicine
12/2021 - 11/2015
2Drug Therapy (Chemotherapy)
01/2021 - 04/2018
2Nephrectomy
04/2019 - 04/2016
2Lithotripsy (Extracorporeal Shockwave Lithotripsy)
10/2008 - 01/2007